The hTert trial will be ground-breaking, but I expect combined therapies to be treating 85% of cancers, not just one universal one. But we'll have to see. We could be pleasantly surprised!
When encountering a new basher or pumper from another board, perform the following:
1. Red thumb the original post.
2. Report the user as abuse.
3. Place the user on permanent ignore.
That's the only way we're going to remove malcontents from this board.
Go INO! GLTA!
This is all that you need to know from the authors conclusion:
"Specifically, we find that reverse split firms with the pre-split share price below $5 and the target post-split price above $5 attract significantly more institutional investment than the control group of non-reverse-split firms, reverse split firms with the pre- and target post-split price both below $5, and reverse split firms with the pre-split price already above $5."
How about a title which instead read:
"3 Stocks Crushed by the Market LAST Week"
Their current title is a misleading and smacks of manipulation and an attempt to drive down the prices of these three stocks THIS week?
What was the INTENT of the article and title?
INO's stock price is literally "starved" for news.
In the absence of revenue, news is the ONLY thing which will drive the stock price higher.
Hopefully we'll get "great" news in the next 30-60 days concerning the P2 results. If positive, we could easily see a "double" from here on such news.
Cramer and "The Street" are clearly behind this organized and orchestrated bear raid. It couldn't be more clear. All three of the "hit piece" articles which came out today were authored by "The Street." Here are their titles:
Why Inovio Pharmaceuticals (INO) Stock Rose, Then Plunged Today
Perilous Reversal Stock: Inovio Pharmaceuticals (INO)
Inovio CEO Preps Retail Investors for Drug Study Failure
These people should be in prison working for pennies an hour instead of destroying millions of dollars in market cap and people's life savings as their calling. What a poor excuse for the human species they are. "The Syndicate" and "The Street" have the same address, it would seem. Sad.
How does it feel to be characterized as "inane" by some of the smartest people on the planet?
How does it feel to be out-classed and up-staged by a college student?
How does it feel to be universally hated by thousands of people?
Will you tell us when you'll be having your next temper tantrum?
Clearly a coordinated effort by Cramer and "The Street"
"They" promoted all (3) negative articles today. Coincidence? Hardly.
AF is just a "sell-side" analyst who works for them. He's their front man, and he loves negative attention. Maybe he was beaten as a baby.
Quoted from IHUB:
He said that they were going to do the Phase IIb with a combination of PD-1 straight up. But no PD-1 drugs are on the market yet (earliest is Merck in November) so how would we obtain it to do combination trials? Since, setup and discussion of PIIb trials with FDA is 2 weeks away, no way would they delay 6 months for drug to get on market to start the trials.
Answer: We will get it through a partnership from a partner who is researching PD-1 (Roche, Merck, BMS).
The way I read today's news as a whole is that their will absolutely be a partnership for the combo Phase 2B trial with a PD-1. Let the bidding begin.
The private placement I believe was hinted at in Dr. Pierce's discussion where he mentioned that they are spending a lot of resources in R&D in Seattle developing new pipelines, not even cancer related but indications in the immune system.
I'm curious to see what Punit says tomorrow but I believe ONCS wants to expand their pipeline a lot more and the private placement will help them do that quicker than if they wait.
On May 26, the stock price was .74. It's now .71. Since then we have incredible data, institutions buying in, imminent partnership(s), potential licencing deals, etc. It's all good.
Bump. Thanks alwayslong337 for bringing this research (based on REAL data) to our attention.
Get it, shorty? Your days are numbered.
It was clearly nothing but manipulation.
Have you ever seen the video where Cramer brags how he cheats the system, yet claims it's legal and morally OK? I don't know how CNBC puts up with him. Maybe they are owned by crooks too.
Summer Street chief scientific officer holds an analyst/industry conference call:
Chief Scientific Officer Classen discusses Inovio's VGX-3100 for the treatment of Cervical Dysplasia on an Analyst/Industry conference call to be held on May 20 at 11 am.
This should raise some analysts estimates!
I bet that ONCS was not mentioned either?
Believe me, shares are being accumulated in both INO and ONCS behind the scenes.
When they want to push this way higher, they will. Hold, and be rewarded.
I don't believe the HPV P2 data release to be a true binary event, but rest assured it will be the most important event in the company's history. Failure will put a lot of pressure on VGX-3112 to succeed. Success will validate the technology platform and approach.
P2 failure =~70% haircut
P2 success =~ 70-150% pop (depending on the data)
I believe success probability to be about 80%.
Yep, that' a wildcard in all of this.
You'd like to think it's an even playing field, but it's not. Big Pharma most certainly has some influence with the FDA. But we'll see.
Regardless, we have cancer on the run!
In fact, I bought more @ 9.23/share. Long-term, assuming good P2 data, we'll be able to put this behind us.
I'm just #$%$ that AF and "The Street" just stole $165M from weak retail investors.
(I guess they didn't steal from Institutions, right? Go figure that ruse out.)
I tried to comment on the article, but MF wouldn't let me. I wrote to the editors, instead.
If someone can copy and paste the text above into the comment section for the article, it would be great. Thanks!
"Thumbs down" is an interesting response to "we have cancer on the run."
There are some very sick people out there. I hope that Inovio develops a vaccine so that their ilk is never reproduced in the human genome again. Sick.